BACKGROUND: Ischemia-reperfusion (I/R) is the main cause of acute kidney injury (AKI) in patients. We investigated renal microRNA (miRNA) expression profiles and the time course of changes in selected miRNA expressions after renal I/R to characterize the miRNA network activated during development and recovery from AKI. METHODS AND RESULTS: One day after lethal (30 minutes) and sublethal (20 minutes) renal ischemia, AKI was verified by renal histology (tubular necrosis, regeneration), blood urea nitrogen (BUN) level, renal mRNA expression, and plasma concentration of neutrophil gelatinase-associated lipocalin (NGAL) in C57BL/6J mice. On the first day after 30-minute, lethal I/R miR-21, miR-17-5p, and miR-106a were elevated out of the 21 miRNAs successfully profiled on the Luminex multiplex assay. After 20-minute, sublethal I/R, renal miR-17-5p and miR-106a expressions were elevated on the first and second days of reperfusion, while miR-21 expression increased later and lasted longer. Renal miR-17-5p and miR-21 expressions correlated with each other. Renal function returned to normal on the fourth day after sublethal I/R. CONCLUSIONS: Our results demonstrate that besides miR-21, miR-17-5p, and miR-106a are additionally activated during the maintenance and recovery phases of renal I/R injury. Furthermore, a correlation between renal miR-17-5p and miR-21 expressions warrants further investigation of how they may influence each other and the outcome of renal ischemia-reperfusion injury.
Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury.
小鼠肾脏缺血再灌注损伤期间 miR-17 家族和 miR-21 的激活
阅读:6
作者:Kaucsár Tamás, Révész Csaba, Godó Mária, Krenács Tibor, Albert Mihály, Szalay Csaba Imre, Rosivall László, Benyó Zoltán, Bátkai Sándor, Thum Thomas, Szénási Gábor, Hamar Péter
| 期刊: | Nucleic Acid Therapeutics | 影响因子: | 4.700 |
| 时间: | 2013 | 起止号: | 2013 Oct;23(5):344-54 |
| doi: | 10.1089/nat.2013.0438 | 研究方向: | 毒理研究 |
| 疾病类型: | 肾损伤 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
